BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis
早期多发性骨髓瘤中的 BRAF V600E 突变：对广谱药物反应良好且与预后无关
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/bcj.2015.24
E H Rustad, H Y Dai, H Hov, E Coward, V Beisvag, O Myklebost, E Hovig, S Nakken, D Vodák, L A Meza-Zepeda, A K Sandvik, K F Wader, K Misund, A Sundan, H Aarset, A Waage2
